103 results on '"prescription drugs"'
Search Results
2. Recent applications of high-performance thin-layer chromatography (HPTLC) in forensic drug analysis
3. Availability and Cost of Expensive and Common Generic Prescription Drugs: A Cross-sectional Analysis of Direct-to-Consumer Pharmacies
4. Do School-Level Anti-Bullying Interventions Affect Prescriptions of Prescribed Drugs in Young Adulthood? A Case Using the Olweus Bullying Prevention Program
5. Prescription drug monitoring program in Australia: a qualitative study of stakeholders’ experiences and perceptions of a state-wide implementation
6. Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder
7. Using a mobile application to reduce potentially inappropriate prescribing for older Brazilian adults in primary care: a triple-blind randomised clinical trial
8. Sozialrechtliche Voraussetzungen eines ausnahmsweise zulässigen „off-label-use“
9. Promoting Prescription Drug Safety Skills in School: Evaluating the Effectiveness of a Technology-Based Curriculum
10. Polypharmacy and medication fill nonadherence in a population-based sample of adolescent and young adult cancer survivors, 2008–2017
11. Schmerzmittelgebrauch in Deutschland: Eine Erhebung über die Jahre 2008 bis 2019
12. Killing pain?: a population-based registry study of the use of prescription analgesics, anxiolytics, and hypnotics among all children, adolescents and young adults in Norway from 2004 to 2019
13. Influence of non-osteoporotic treatments in patients on active anti-osteoporotic therapy: evidence from the OSTEOMED registry
14. Prevalence and associated factors of non-medical use of prescription drugs among adolescents in secondary schools in Buea, Cameroon: a cross-sectional study
15. Polypharmacy and prescription medication use in a population-based sample of adolescent and young adult cancer survivors
16. Complexity of Data Displays in Prescription Drug Advertisements for Healthcare Providers
17. Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs’ reimbursements
18. Trends in postoperative opioid prescribing in Ontario between 2013 and 2019: a population-based cohort study
19. Regulation of Drug Prescribing Information in Latin America and the Caribbean
20. The association between the availability of over the counter codeine and the prevalence of non-medical use
21. The association between pharmaceutical innovation and both premature mortality and hospital utilization in Switzerland, 1996–2019
22. The COVID-19 pandemic’s impact on mental health care use among Norwegian students in higher education: a nation-wide register-based pre-post cohort study
23. Identifying target areas of medicines information efforts to pregnant and breastfeeding women by reviewing questions to SafeMotherMedicine: A Norwegian web-based public medicines information service
24. Biennial Analysis of Medication Guide Length and Estimated Readability for New Molecular Entity Drugs, 2011–2017
25. A Dual-Wall 3D-Printed Anti-tampering Medical Bottle
26. Over-the-Counter Drugs: Regulatory Analysis of Warning Letters Between Fiscal Years 2015–2019
27. The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants
28. Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample
29. Incidence of diagnosed pediatric anxiety disorders and use of prescription drugs: a nation-wide registry study
30. Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005–2015
31. Medications and fall risk: a case–control study in nursing home residents in Japan
32. Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial
33. A Response to Meyerson’s Defence of the American Right to Try: Experimenting with hope
34. Use of prescription drugs in the older adult population—a nationwide pharmacoepidemiological study
35. Polypharmacy in older patients at primary care units in Brazil
36. Income Elasticity Decomposition Models and Determinants of U.S. Pharmaceutical Expenditures
37. Safe drugs in drug facilitated crimes and acute intoxications in Northern Italy
38. How do state Medicaid programs determine what substance use disorder treatment medications need prior authorization? An overview for clinicians
39. Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand
40. Self-reported medication in community-dwelling older adults in Germany: results from the Berlin Initiative Study
41. Pre-Incarceration Rates of Nonmedical Use of Prescription Drugs among Black Men from Urban Counties
42. Estimating the Causal Effect of Entry on Generic Drug Prices Using Hatch–Waxman Exclusivity
43. Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending
44. Acute poisoning related to the recreational use of prescription drugs: an observational study from Oslo, Norway
45. Impact of removal and restriction of me-too medicines in a hospital drug formulary on in- and outpatient drug prescriptions: interrupted time series design with comparison group
46. The Impact of Off-Patent Drug Acquisitions on Prices
47. The Landscape of Contract Manufacturing of Sterile Injectable Drugs: Who Is Making What, Where, and for Whom
48. Comparing Adoption of Breakthrough and “Me-too” Drugs Among Medicare Beneficiaries: a Case Study of Dipeptidyl Peptidase-4 Inhibitors
49. Drug innovation, price controls, and parallel trade
50. Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.